SubsidieMeestersFirst in class lateral meniscus prothesis to relieve pain and restore mobility for KOA patients
ATRO Medical's Trammpolin is a minimally invasive knee prosthesis designed to relieve pain and restore mobility in severe KOA patients, aiming for market entry in 2026 with a focus on health economics for reimbursement.
Projectdetails
Introduction
ATRO Medical developed a revolutionary prosthesis that quickly relieves pain and restores mobility for severe KOA patients with a dysfunctional lateral meniscus: Trammpolin.
Procedure Overview
We offer a minimally invasive, low-impact procedure that postpones undesirable TKR and reduces KOA-related healthcare costs and medication dependency, while restoring full knee functioning.
Innovation Details
Our innovation is composed of a dual highly biocompatible polymer that carries the body weight and is uniquely shaped to reproduce the anatomical shape and mechanical properties of the native meniscus.
Technology Validation
The technology has proven itself for the medial meniscus and received the Breakthrough Device Designation of the US FDA in 2020.
Market Entry Strategy
For successful market entry of our lateral Trammpolin in 2026, we aim to:
- Finalize our pre-clinical activities
- Conduct a FIH-study
- Obtain CE-marking
Health Economics Analysis
In parallel, we will perform a health economics analysis as a crucial step towards obtaining reimbursement for large-scale uptake in the medical system.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 2.499.402 |
| Totale projectbegroting | € 3.570.575 |
Tijdlijn
| Startdatum | 1-4-2023 |
| Einddatum | 30-9-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- ATRO MEDICAL BVpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Rebuilding Joint Surface to Prevent Pain and ImmobilityAskel's COPLA® implant promotes cartilage regeneration and quick rehabilitation to prevent osteoarthritis, aiming to establish a gold standard for pain-free joint movement and improved quality of life. | EIC Accelerator | € 2.499.000 | 2022 | Details |
Disruptive, drug free treatment of knee osteoarthritis using novel materials and minimally invasive catheter deliveryEmboSure is a minimally invasive treatment for Knee Osteoarthritis that uses bioresorbable particles to block blood vessels, providing long-term pain relief and halting disease progression for up to 5 years. | EIC Accelerator | € 2.488.572 | 2022 | Details |
The InDx CMC Implant. A new treatment for thumb base joint arthritis.The InDx CMC Implant offers a patented, evidence-based solution for thumb base joint arthritis, aiming to restore joint mobility and eliminate pain for an underserved aging population. | EIC Accelerator | € 2.500.000 | 2022 | Details |
Novel AI-based system for orthopedic surgery to help surgeons fully automate the pre-operative planning of knee osteotomyPeek Health aims to revolutionize orthopedic surgery planning with AI-based PeekMed-Auto, enhancing care quality and reducing costs while targeting over €40M in revenue by 2026. | EIC Accelerator | € 2.287.922 | 2022 | Details |
A breakthrough active immunotherapy for the treatment of osteoarthritisPeptinov aims to halt osteoarthritis progression through a cost-effective immunotherapy that neutralizes IL-6, with promising Phase I results leading to a Phase II trial for out-licensing readiness. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Rebuilding Joint Surface to Prevent Pain and Immobility
Askel's COPLA® implant promotes cartilage regeneration and quick rehabilitation to prevent osteoarthritis, aiming to establish a gold standard for pain-free joint movement and improved quality of life.
Disruptive, drug free treatment of knee osteoarthritis using novel materials and minimally invasive catheter delivery
EmboSure is a minimally invasive treatment for Knee Osteoarthritis that uses bioresorbable particles to block blood vessels, providing long-term pain relief and halting disease progression for up to 5 years.
The InDx CMC Implant. A new treatment for thumb base joint arthritis.
The InDx CMC Implant offers a patented, evidence-based solution for thumb base joint arthritis, aiming to restore joint mobility and eliminate pain for an underserved aging population.
Novel AI-based system for orthopedic surgery to help surgeons fully automate the pre-operative planning of knee osteotomy
Peek Health aims to revolutionize orthopedic surgery planning with AI-based PeekMed-Auto, enhancing care quality and reducing costs while targeting over €40M in revenue by 2026.
A breakthrough active immunotherapy for the treatment of osteoarthritis
Peptinov aims to halt osteoarthritis progression through a cost-effective immunotherapy that neutralizes IL-6, with promising Phase I results leading to a Phase II trial for out-licensing readiness.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
SyCap MechanoAvalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten. | Mkb-innovati... | € 20.000 | 2022 | Details |
Development of a Complete Triple Action Injectable Treatment for OsteoarthritisRelevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients. | EIC Transition | € 2.398.115 | 2022 | Details |
KneeWear - a remotely monitored smart wearable to train gait and reduce hospitalization related to knee osteoarthritisElitac Systems en Moveshelf Labs ontwikkelen een smart wearable en digitaal platform voor het op afstand monitoren en verbeteren van looppatronen bij artrosepatiënten, wat zorgkosten verlaagt en zelfredzaamheid bevordert. | Mkb-innovati... | € 196.910 | 2021 | Details |
OrthoKey precisie diagnose in Totale Knie Arthroplastiek...Het project ontwikkelt een innovatieve methode voor het detecteren van loszittende prothesen, die de diagnostische nauwkeurigheid verbetert naar 95%, en vermindert onnodige revisies en kosten. | Mkb-innovati... | € 20.000 | 2022 | Details |
In Silico Trials for Cartilage Regenerative Medicine ApplicationsThe INSTAnt CARMA project aims to develop and validate a multiscale in silico model for osteoarthritis to optimize drug and tissue-engineered therapies through virtual trials. | ERC Consolid... | € 2.212.385 | 2023 | Details |
SyCap Mechano
Avalanche Medical ontwikkelt een duurzaam kunststof implantaat voor kraakbeendefecten in de knie, gericht op middelbare leeftijd patiënten.
Development of a Complete Triple Action Injectable Treatment for Osteoarthritis
Relevium Ltd aims to validate and commercialize Hydrobloc, a unique therapy that regenerates cartilage, alleviates pain, and improves joint function in osteoarthritis patients.
KneeWear - a remotely monitored smart wearable to train gait and reduce hospitalization related to knee osteoarthritis
Elitac Systems en Moveshelf Labs ontwikkelen een smart wearable en digitaal platform voor het op afstand monitoren en verbeteren van looppatronen bij artrosepatiënten, wat zorgkosten verlaagt en zelfredzaamheid bevordert.
OrthoKey precisie diagnose in Totale Knie Arthroplastiek...
Het project ontwikkelt een innovatieve methode voor het detecteren van loszittende prothesen, die de diagnostische nauwkeurigheid verbetert naar 95%, en vermindert onnodige revisies en kosten.
In Silico Trials for Cartilage Regenerative Medicine Applications
The INSTAnt CARMA project aims to develop and validate a multiscale in silico model for osteoarthritis to optimize drug and tissue-engineered therapies through virtual trials.